InvestorsHub Logo
Followers 3
Posts 400
Boards Moderated 1
Alias Born 07/12/2005

Re: noretreat post# 22765

Thursday, 01/31/2013 1:52:50 PM

Thursday, January 31, 2013 1:52:50 PM

Post# of 403504
The quote I published talked about extrapolating from observed effectiveness in pre-clinical (ie, mouse) models to phase 2 clinical results. If you go to CTIX's website and read through their presentations, you will observe that Kevetrin was shown to be active in 100% of the mouse models they tried. The quote indicated a ~ 50% likelihood of positive phase 2 results if a cancer drug showed positive activity in at least 33% of mouse cancer models. So, since Kevetrin showed significant activity (ie, effectiveness) in 100% of the mouse models, my conclusion is that the likelihood of Kevetrin being successful in phase 2 trials is substantially greater than 50%.

A1
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News